Get started

Medipharm Labs Corporation

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

MEDIF chart

Key stats

Market capitalization
23.575MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0499USD
Net income
−22.118MUSD
Revenue
16.316MUSD
Shares float
397.474M
Beta
1.17

About Medipharm Labs Corporation

Sector
Process Industries
Industry
Agricultural Commodities/Milling
CEO
David A. Pidduck
Website
medipharmlabs.com
Headquarters
Barrie
Employees
130
Founded
2015
ISIN
CA58504D1006

MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.

Ideas

GOLDEN CROSSToday, Medipharm Labs's 50-day moving average line crossed above its 200-day moving average line, forming a GOLDEN CROSS, a STRONG BULLISH signal. Today, the stock went up by 13.33% on more than 4 times average daily volume. Tradingview's technical analysis summary is BUY: www.tradingview.com GL
Long
3
IMMINENT GOLDEN CROSSMedipharm Labs's 50-day and 200-day moving average lines are a quarter of a penny from forming a GOLDEN CROSS, a strong BULLISH signal. Extrapolation of these lines strongly suggests that they might form a GOLDEN CROSS this coming week. Also, the Accumulation/Distribution indicator has clearly bee
Long
POTENTIAL GOLDEN CROSSAn extrapolation of MEDIPHARM LABS' 50-day and 200-day moving average lines suggests a GOLDEN CROSS should take place early next year. According to The Globe and Mail, the target price for LABS is $0.10: www.theglobeandmail.com This represents a 20% upside potential. GLTA!
Long
From 5.50 to under 0.50 stock, would you buy ?Read latest news here , here Think about stock investment like America got Talent show. If a stock has good potential but lack coverage by analysts, institutional buyers, media coverage, etc, it would take some time for investors to take notice. The show or the analysts coverage, etc are the p
3
Medif I currently do not own this stock but am looking to purchase soon for the potential run. I am no expert do your own reasearch , but im glad to share my opinion and input and learn together. Good Luck everyone! if you want to play it safe you can also ride it up to the 200dma if you keep an eye on it
Long
CLIMBING ABOVE 50-DAY MOVING AVERAGE LINEToday Medipharm Labs climbed above its 50-day moving average line, a strong BULLISH signal. It did so by going up by 27.12% on more than 3 times average daily volume. In the process, it filled a major gap. TradingView's technical analysis summary is BUY: www.tradingview.com This stock has a con
Long
2
This may be the bottom of LABSLooking at the weekly we can see there is a bullish divergence and there seems to be another one forming on the daily. Looks like a great recipe for a technical bottom. Of course this trade will largely depend on the earnings. breaking of this trendline would be extremely bullish and picking some
Long
LABS.TO - Filled the gap. $2.50 price target from Canaccord.LABS presents a very good entry near .84 gap fill. Canaccord analyst has revised the price target to $2.50 after EU deal announcement and the company continues to produce excellent news flow. Strong support in the low .80s. Gap above at 1.69. Positive MACD divergence. Sector is finally turning bulli
Long
LABS - On serious reversal watch for descending wedge breakCannabis sector reverses this will reverse hard MM's left big gaps above that would see 3-4x return when descending wedge is broken. Low risk at these levels imo and very high reward. Currently depressed in a depressed sector that has huge growth prospects.
Long

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.3Good
Learn more

See all brokers 

Sparks

Curated watchlists where MEDIF is featured.

See all sparks